Cargando…
Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?
The current spread of multi-drug resistance in a number of key pathogens and the lack of therapeutic solutions in development to address most of the emerging infections in the clinic that are difficult to treat have become major concerns. Microbial natural products represent one of the most importan...
Autor principal: | Genilloud, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316141/ https://www.ncbi.nlm.nih.gov/pubmed/30257490 http://dx.doi.org/10.3390/antibiotics7040085 |
Ejemplares similares
-
Actinomycetes: The Antibiotics Producers
por: Mast, Yvonne, et al.
Publicado: (2019) -
Artificial Chromosomes to Explore and to Exploit Biosynthetic Capabilities of Actinomycetes
por: Alduina, Rosa, et al.
Publicado: (2012) -
The role of the clinician in the multi-omics era: are you ready?
por: van Karnebeek, Clara D. M., et al.
Publicado: (2018) -
Production of Ramoplanin and Ramoplanin Analogs by Actinomycetes
por: de la Cruz, Mercedes, et al.
Publicado: (2017) -
Concepts and Methods to Access Novel Antibiotics from Actinomycetes
por: Hug, Joachim J., et al.
Publicado: (2018)